文献速递生殖医学

比较妊娠载体与子宫移植治疗子宫因素不孕的成本效果分析

Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis.
PubMed 文献 · Fertil Steril · 2025-01-22

该成本效果分析用决策树模型比较妊娠载体(GC)与子宫移植(UTX)治疗绝对子宫因素不孕。模拟中GC组42%出生2个孩子而UTX组仅17%。模型提示GC目前更具成本效果,但拥有亲生孩子的意愿未被成本分析捕捉。

要点

  • 模拟1万次迭代,GC组42%出生2个孩子,UTX组17%;UTX组56%无孩子出生,GC组16%。
  • UTX每次移植活产概率超过85%、启动成本低于13,646.28美元或GC成本超过359,200美元时,UTX不再被绝对支配。

核心结论

  • 模型提示,目前GC用于治疗绝对子宫因素不孕比UTX更具成本效果。
  • 但拥有自己孩子的愿望是成本分析未捕捉的无形因素,UTX成功率提高或成本降低可能在未来改变这些结果。

研究设计与样本

  • 成本效果分析,采用决策树数学模型比较GC与UTX。
  • 成本来自已发表文献,涵盖实体器官移植、免疫抑制、GC获取、体外受精、胚胎植入前遗传学检测和冻胚移植(FET)。
  • 假设移植物失败立即发生,FET在移植后至少6个月进行。

主要发现

  • 1万次模拟迭代后,GC组42%出生2个孩子,UTX组17%;UTX组56%无孩子出生,GC组16%。
  • 所有成本参数±75%(GC 39,292–275,044美元 vs UTX 390,761–2,735,329美元)及其他输入参数±20%(移植物失败21%–31%、每次胚胎移植活产29%–78%)的确定性和概率敏感性方差在>99%模拟场景中产生相同结局。
  • 分娩至后续FET之间免疫抑制时间变化(2–18个月)也产生相同结局。
  • 若UTX每次移植活产概率增至85%以上、UTX启动成本降至<13,646.28美元或GC成本增至>359,200美元,UTX不再被绝对支配。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出,拥有自己孩子的愿望是成本分析未捕捉的无形因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the cost-effectiveness of a gestational carrier (GC) to a uterine transplantation (UTX) in the treatment of absolute uterine-factor infertility. DESIGN: We performed a cost-effectiveness analysis using a decision-tree mathematical model comparing a GC with a UTX. SUBJECTS: Published literature was used to derive costs for solid organ transplant, immunosuppression, GC obtainment, in vitro fertilization, preimplantation genetic testing, and frozen embryo transfer (FET). EXPOSURE: Gestational modality: GC or UTX. We assumed graft failures occurred immediately and FETs at least 6 months after transplant. MAIN OUTCOME MEASURES: The primary outcomes were costs per live birth, number of children born, and quality-adjusted life years for each gestational modality. RESULTS: Uterine transplantation was more expensive than a GC by $1.4 million with a lower utility by 23.74 quality-adjusted life years using the same average number of children born per 2 FETs. After 10,000 simulated iterations, the GC arm had 2 children born 42% of the time, compared with only 17% of the time in the UTX arm. No children were born 56% of the time in the UTX arm vs. 16% for the GC arm. Deterministic and probabilistic sensitivity variance of all cost parameters by ±75% ($39,292-$275,044 for GC vs. $390,761-$2,735,329 for UTX) and other input parameters by ±20%, including graft failure (21%-31%) and live birth per embryo transfer (29%-78%), produced the same outcomes in >99% of scenarios simulated, as did variation in immunosuppression time (2-18 months) between delivery and subsequent FET. UTX was no longer absolutely dominated if the probability of a live birth per transfer using UTX increased beyond 85%, startup cost for UTX decreased to <$13,646.28, or GC costs increased to >$359,200. CONCLUSION: Our model suggests that GC use is currently more cost effective than UTX for treating absolute uterine-factor infertility. However, the desire to carry one's own child is an intangible factor not captured in cost analyses, and improvements in UTX success rates or reduced costs may alter these results in the future.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Combs JC, Yamasaki MU, Dougherty M, et al. Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis. Fertil Steril. 2025. PMID: 39848421. doi:10.1016/j.fertnstert.2025.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。